CoV-GLUEGenomeCountriesLineagesMutationsInsertionsDeletionsUpdated:

CoV-GLUE | Mutations | Mutation

CoV-GLUE Mutation: ORF = ORF1ab/nsp3 : Mut = A480A

Details of the codons used for the mutation across all lineages (CodonProp is the proportion each codon is used for this AA mutation):

ORFCodonNumMutORF1abMutMutTypeRefCodonMutCodonAACountCodonCountCodonPropGenome Position
ORF1ab/nsp3480A480AA1298AsyngcTgcC1901440.7578954157-4159
ORF1ab/nsp3480A480AA1298AsyngcTgcA190240.1263164157-4159
ORF1ab/nsp3480A480AA1298AsyngcTgcG190220.1157894157-4159

Details of the mutation A480A within lineages (LineageCodonProp is the proportion the codon is observed at, at this particular site, on each lineage):

ORFCodonNumMutRefCodonMutCodonCodonCountAACountLineageLineageCodonProp
ORF1ab/nsp3480A480AgcTgcC144190All0.000028
ORF1ab/nsp3480A480AgcTgcA24190All0.000005
ORF1ab/nsp3480A480AgcTgcG22190All0.000004
ORF1ab/nsp3480A480AgcTgcC2931B.1.1.70.000026
ORF1ab/nsp3480A480AgcTgcG131B.1.1.70.000001
ORF1ab/nsp3480A480AgcTgcA131B.1.1.70.000001
ORF1ab/nsp3480A480AgcTgcC1722AY.40.000026
ORF1ab/nsp3480A480AgcTgcG322AY.40.000005
ORF1ab/nsp3480A480AgcTgcA222AY.40.000003
ORF1ab/nsp3480A480AgcTgcC1919AY.1020.000504
ORF1ab/nsp3480A480AgcTgcA716B.1.617.20.000026
ORF1ab/nsp3480A480AgcTgcC616B.1.617.20.000023
ORF1ab/nsp3480A480AgcTgcG316B.1.617.20.000011
ORF1ab/nsp3480A480AgcTgcC1010B.1.4290.000235
ORF1ab/nsp3480A480AgcTgcG59AY.440.00003
ORF1ab/nsp3480A480AgcTgcC49AY.440.000024
ORF1ab/nsp3480A480AgcTgcC77AH.11
ORF1ab/nsp3480A480AgcTgcA34AY.430.000013
ORF1ab/nsp3480A480AgcTgcC14AY.430.000004
ORF1ab/nsp3480A480AgcTgcC44B.1.36.80.004
ORF1ab/nsp3480A480AgcTgcA44B.1.5260.000094
ORF1ab/nsp3480A480AgcTgcC44C.260.029412
ORF1ab/nsp3480A480AgcTgcC23AY.1030.000012
ORF1ab/nsp3480A480AgcTgcA13AY.1030.000006
ORF1ab/nsp3480A480AgcTgcG33B.1.1.500.002037
ORF1ab/nsp3480A480AgcTgcC33B.1.1.630.001157
ORF1ab/nsp3480A480AgcTgcC33B.1.20.000026
ORF1ab/nsp3480A480AgcTgcG12AY.1180.000063
ORF1ab/nsp3480A480AgcTgcC12AY.1180.000063
ORF1ab/nsp3480A480AgcTgcC22AY.470.000062
ORF1ab/nsp3480A480AgcTgcA22AY.580.001815
ORF1ab/nsp3480A480AgcTgcA12B.10.000009
ORF1ab/nsp3480A480AgcTgcG12B.10.000009
ORF1ab/nsp3480A480AgcTgcC12B.1.10.000018
ORF1ab/nsp3480A480AgcTgcA12B.1.10.000018
ORF1ab/nsp3480A480AgcTgcC22B.1.1.2510.015873
ORF1ab/nsp3480A480AgcTgcA22B.1.1.4470.071429
ORF1ab/nsp3480A480AgcTgcC22B.1.1.5190.000079
ORF1ab/nsp3480A480AgcTgcG22B.1.1770.000026
ORF1ab/nsp3480A480AgcTgcC22B.1.258.170.000208
ORF1ab/nsp3480A480AgcTgcC22P.10.000032
ORF1ab/nsp3480A480AgcTgcC22Q.30.00029
ORF1ab/nsp3480A480AgcTgcC110.055556
ORF1ab/nsp3480A480AgcTgcC11A.23.10.000704
ORF1ab/nsp3480A480AgcTgcC11AY.1210.000135
ORF1ab/nsp3480A480AgcTgcC11AY.260.000028
ORF1ab/nsp3480A480AgcTgcC11AY.300.000396
ORF1ab/nsp3480A480AgcTgcC11AY.390.000025
ORF1ab/nsp3480A480AgcTgcC11AY.50.000021
ORF1ab/nsp3480A480AgcTgcC11AY.5.40.000277
ORF1ab/nsp3480A480AgcTgcC11AY.540.000095
ORF1ab/nsp3480A480AgcTgcC11AY.60.000041
ORF1ab/nsp3480A480AgcTgcC11AY.610.000105
ORF1ab/nsp3480A480AgcTgcC11AY.9.20.000037
ORF1ab/nsp3480A480AgcTgcC11B.1.1.1180.010204
ORF1ab/nsp3480A480AgcTgcC11B.1.1.700.000341
ORF1ab/nsp3480A480AgcTgcG11B.1.177.820.000477
ORF1ab/nsp3480A480AgcTgcC11B.1.214.10.02
ORF1ab/nsp3480A480AgcTgcC11B.1.214.20.0006
ORF1ab/nsp3480A480AgcTgcG11B.1.258.140.00098
ORF1ab/nsp3480A480AgcTgcC11B.1.4270.00005
ORF1ab/nsp3480A480AgcTgcC11B.1.5510.00129
ORF1ab/nsp3480A480AgcTgcC11B.1.5750.000303
ORF1ab/nsp3480A480AgcTgcG11B.1.5950.000261
ORF1ab/nsp3480A480AgcTgcC11P.20.000187
ORF1ab/nsp3480A480AgcTgcC11Q.10.000126

CoV-GLUE is still in development. CoV-GLUE was originally developed as part of COG-UK by Josh Singer using the GLUE framework at the MRC-University of Glasgow Centre for Virus Research (CVR). In 2021 it was redeveloped by Richard Orton to scale to the millions of genome sequences available. We acknowledge support from the MRC (MC_UU_12014/12), WT (220977/Z/20/Z) and UKRI G2P (MR/W005611/1). Please contact Richard Orton with any queries: Richard.Orton@glasgow.ac.uk

CoV-GLUE uses sequence data from GISAID. GISAID data provided via this web application is subject to GISAID's Terms and Conditions.